Skip to main content

Table 1 The relationship between circDNAJC11 expression and the clinicopathological characteristics of 80 BC patients

From: CircDNAJC11 interacts with TAF15 to promote breast cancer progression via enhancing MAPK6 expression and activating the MAPK signaling pathway

Characteristics

circRNA

Chi-square

P value

Low

High

Age

 < 50

14

24

0.013

0.908

 ≥ 50

16

26

Grade

I-II

18

21

2.432

0.119

III

12

29

T stage

T1

21

16

10.891

0.001

T2-3

9

34

N stage

N0

17

23

0.853

0.356

N1-3

13

27

TNM stage

I-II

12

30

3.008

0.083

III

18

20